ÂÜÀòÂÒÂ×

Don DeGolyer is an experienced healthcare executive with a robust background in leadership and advisory roles. Currently serving as a Board Director at Emergent BioSolutions and a Board Member at Xevant, DeGolyer also acts as a Senior Advisor at Formation Bio. Previous roles include Board Director positions at HLS Therapeutics Inc., TYME Technologies Inc., and Vertice Pharma, where DeGolyer was also the Founder and CEO. Additional experience includes serving as Chief Operating Officer at Endo International plc and CEO at Sandoz Inc., with significant contributions during tenure at Novartis as Senior Vice President for Managed Care and Established Products. Educational qualifications encompass a Bachelor's degree from the University of Rochester, an MBA in Marketing from Fairleigh Dickinson University, and an Executive MBA from Harvard Business School.